The right to representation in board of directors in joint stock companies within the scope of the article 360 of TCC
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
Today, as an economically important and effective company type in many areas, joint stock companies are managed on the basis of majority vote since they are founded on capital basis. The management of joint stock companies on the basis of majority may conflict with the interests of the groups and the minority who cannot have a say in the management of the company. In order to prevent these conflicts of interest, pursuant to the right of representation, which has reached the legal ground with Article 360 of the TCC ın case is stated in the articles of association, certain share groups, shareholders consisting of a certain group in terms of their qualities and nature, and minorities can be granted the right to be represented on the board of directors. In our study, the right to representation which was referred to as the group privilege before the TCC Numbered 6102 and which has been normatively regulated by Art.360 for the first time will be examined.
Author
Ayşe Arat
How to Cite
Ayşe Arat (Master Thesis). The right to representation in board of directors in joint stock companies within the scope of the article 360 of TCC, 2020, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)